STAT3 and breast cancer: SDC1 is capable of modulating breast cancer stem cell phenotypes via interleukin (IL)-6/signal transducers and activators of transcription 3 (STAT3), Notch, and epidermal growth factor receptor (EGFR) signaling pathways [69].